Compare AEON & CLWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AEON | CLWT |
|---|---|---|
| Founded | N/A | 1971 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional and commerical equipment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.0M | 11.3M |
| IPO Year | 2021 | 1996 |
| Metric | AEON | CLWT |
|---|---|---|
| Price | $0.23 | $1.46 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $1.82 | N/A |
| AVG Volume (30 Days) | 1.3M | ★ 1.4M |
| Earning Date | 11-13-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 8.49% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $17.56 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.18 | $0.99 |
| 52 Week High | $1.45 | $2.68 |
| Indicator | AEON | CLWT |
|---|---|---|
| Relative Strength Index (RSI) | 40.82 | 49.52 |
| Support Level | $0.18 | $1.46 |
| Resistance Level | $0.33 | $1.74 |
| Average True Range (ATR) | 0.03 | 0.14 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 8.72 | 20.18 |
AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.
Euro Tech Holdings Co Ltd is mainly a distributor of a wide range of water treatment equipment, laboratory instruments, analyzers, test kits, and related supplies, and power generation equipment, including recorders and power quality analyzers. The Company acts as an exclusive or non-exclusive distributor for manufacturers of such equipment to commercial customers and governmental agencies in Hong Kong and mainland China, as well as commercial customers in Macau. It has two operating segments: Trading and manufacturing, which generate maximum revenue and act as a distributor of water treatment equipment, laboratory instruments, analyzers, test kits, related supplies, and power generation equipment; and the Engineering segment. The Company generates maximum revenue from the PRC.